JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265818

Human TAF12 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TAF12 KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.

View Alternative Names

TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa, TAF12_HUMAN, TAF2J, TAFII-20/TAFII-15, TAFII20, Transcription initiation factor TFIID 20/15 kDa subunits, Transcription initiation factor TFIID subunit 12

1 Images
Sanger Sequencing - Human TAF12 knockout HeLa cell line (AB265818)
  • Sanger seq

Unknown

Sanger Sequencing - Human TAF12 knockout HeLa cell line (AB265818)

Homozygous : 1 bp insertion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265818-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265818-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265818 Human TAF12 knockout HeLa cell line", "number":"AB265818-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265818-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265818 Human TAF12 knockout HeLa cell line", "number":"AB265818-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265818-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265818-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265818 Human TAF12 knockout HeLa cell line", "number":"AB265818-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265818-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265818 Human TAF12 knockout HeLa cell line", "number":"AB265818-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TAF12
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TAF12 also known as Transcription initiation factor TFIID subunit 12 is a critical component of the transcription machinery specifically within the TFIID complex. This protein weighs approximately 22 kilodalton and acts as a bridge connecting different proteins within the transcriptional complex. TAF12 shows expression in various tissues with higher levels observed in actively dividing cells like those in the immune system or during embryonic development. Its expression pattern suggests a role in processes that require rapid gene expression changes.
Biological function summary

TAF12 contributes to the formation and stability of the TFIID complex which is essential for the initiation of transcription by RNA polymerase II. As part of this complex TAF12 helps recognize and bind to the core promoter elements of genes facilitating the assembly of the pre-initiation complex. This process drives gene expression that is responsive to various physiological signals. TAF12's interaction with other TAF (TBP-associated factors) proteins ensures precision in the selection of transcription start sites.

Pathways

TAF12 integrates into gene expression pathways affecting cellular proliferation and differentiation. Its role in the canonical Wnt signaling pathway is significant a pathway that regulates important aspects of development and cell signaling. TAF12 also interacts with proteins such as TAF1 and TBP which jointly influence transcription initiation. These protein interactions are fundamental for the regulation of genes that control cell cycle progression and response to external growth signals.

TAF12's function relates closely to cancer and neurodegenerative diseases. Its overexpression or misregulation may lead to oncogenesis as aberrant transcription can drive uncontrolled cell proliferation. In cancers TAF12's interaction with other transcription factors like the ETS family might contribute to tumorigenesis. Additionally alterations in TAF12 might be implicated in neurodegenerative disorders like Alzheimer's disease where the regulation of neuronal gene expression is disrupted. Studies are ongoing to understand fully how TAF12 and its associated proteins influence disease pathology and progression.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com